These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 26542609)
61. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2]. Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769 [TBL] [Abstract][Full Text] [Related]
62. Tumor-to-tumor metastasis from appendiceal adenocarcinoma to an ovarian mature teratoma, mimicking malignant transformation of a teratoma: a case report. Yano M; Katoh T; Hamaguchi T; Kozawa E; Hamada M; Nagata K; Yasuda M Diagn Pathol; 2019 Aug; 14(1):88. PubMed ID: 31409389 [TBL] [Abstract][Full Text] [Related]
63. Immunophenotypic Comparison of Neoplasms of the Appendix, Right Colon, and Left Colon in Search of a Site-Specific Phenotypic Signature. Mesa H; Manivel JC; Larson WS; Dachel SK; Reinink AR; Jessurun J Int J Surg Pathol; 2020 Feb; 28(1):20-30. PubMed ID: 31271071 [No Abstract] [Full Text] [Related]
64. Immunohistochemistry features and molecular pathology of appendiceal neoplasms. Mikaeel RR; Young JP; Tapia Rico G; Hewett PJ; Hardingham JE; Uylaki W; Horsnell M; Price TJ Crit Rev Clin Lab Sci; 2021 Sep; 58(6):369-384. PubMed ID: 33569997 [TBL] [Abstract][Full Text] [Related]
65. Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. Raspollini MR; Amunni G; Villanucci A; Baroni G; Taddei A; Taddei GL Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):127-31. PubMed ID: 15354737 [TBL] [Abstract][Full Text] [Related]
66. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. McKenney JK; Soslow RA; Longacre TA Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868 [TBL] [Abstract][Full Text] [Related]
67. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype. Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039 [TBL] [Abstract][Full Text] [Related]
68. Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases. Malmros K; Lindholm A; Vidarsdottir H; Jirström K; Nodin B; Botling J; Mattsson JSM; Micke P; Planck M; Jönsson M; Staaf J; Brunnström H Virchows Arch; 2024 Aug; 485(2):347-357. PubMed ID: 37349623 [TBL] [Abstract][Full Text] [Related]
69. Intestinal-Type Adenocarcinoma Arising in a Mature Cystic Teratoma of the Ovary. Clark ME; Will MD Int J Gynecol Pathol; 2016 Jul; 35(4):352-6. PubMed ID: 26937866 [TBL] [Abstract][Full Text] [Related]
70. Immunohistochemical expression of SATB2 and PAX8 in differentiating primary from metastatic ovarian mucinous neoplasms. El Ghondakly RA; El Haddad SI; AbdelSalam MM; Nada OH; Farid RM; Farid LM APMIS; 2024 Oct; 132(10):706-717. PubMed ID: 39005045 [TBL] [Abstract][Full Text] [Related]
71. Gross mucinous multinodular appearance aids in the identification of ovarian metastases in low-grade appendiceal mucinous neoplasms during intraoperative consultation. Yoshida H; Tanaka H; Tsukada T; Abeto N; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T Ann Diagn Pathol; 2021 Feb; 50():151641. PubMed ID: 33189966 [TBL] [Abstract][Full Text] [Related]
72. Synchronous Low-grade Appendiceal Mucinous Neoplasm and Primary Peritoneal Low-grade Serous Carcinoma: A First Description of These 2 Neoplasms Presenting Together as Suspected Peritoneal Carcinomatosis. Sekulic M; Pichler Sekulic S; Movahedi-Lankarani S Int J Gynecol Pathol; 2017 Sep; 36(5):459-465. PubMed ID: 27684884 [TBL] [Abstract][Full Text] [Related]
73. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study. Dragomir A; de Wit M; Johansson C; Uhlen M; Pontén F Am J Clin Pathol; 2014 May; 141(5):630-8. PubMed ID: 24713733 [TBL] [Abstract][Full Text] [Related]
74. FOXA1 is expressed in ovarian mucinous neoplasms. Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418 [TBL] [Abstract][Full Text] [Related]
75. Differentiating primary and extragenital metastatic mucinous ovarian tumours: an algorithm combining PAX8 with tumour size and laterality. Hu A; Li H; Zhang L; Ren C; Wang Y; Liu Y; Liu C J Clin Pathol; 2015 Jul; 68(7):522-8. PubMed ID: 25827135 [TBL] [Abstract][Full Text] [Related]
76. Pathology of primary and metastatic mucinous ovarian neoplasms. Leen SL; Singh N J Clin Pathol; 2012 Jul; 65(7):591-5. PubMed ID: 22075188 [TBL] [Abstract][Full Text] [Related]
77. GATA4 is diagnostically useful for distinguishing primary ovarian mucinous carcinomas from metastatic colorectal adenocarcinomas to the ovary. Mochizuki K; Tahara I; Inoue T; Kasai K; Kondo T Histol Histopathol; 2024 Jun; ():18783. PubMed ID: 38973377 [TBL] [Abstract][Full Text] [Related]
78. SATB2 is expressed in Merkel cell carcinoma. Fukuhara M; Agnarsdóttir M; Edqvist PH; Coter A; Ponten F Arch Dermatol Res; 2016 Aug; 308(6):449-54. PubMed ID: 27262585 [TBL] [Abstract][Full Text] [Related]
79. A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary. Chelariu-Raicu A; Holley E; Mayr D; Klauschen F; Wehweck F; Rottmann M; Kessler M; Kaltofen T; Czogalla B; Trillsch F; Mahner S; Schmoeckel E Int J Gynecol Cancer; 2022 May; 32(5):662-668. PubMed ID: 35185017 [TBL] [Abstract][Full Text] [Related]
80. [Primary mucinous gland lesions of fallopian tube: a clinicopathological analysis of fourteen cases]. Zhang LL; Xu Y; Ji ST; Ning Y; Gu WY Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):546-551. PubMed ID: 38825898 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]